Current Ratio of C4 Therapeutics, Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
C4 Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • C4 Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 554%, a 1.7% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

C4 Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 554% -9.3% -1.7% 30 Sep 2025
Q2 2025 569% -7.6% -1.3% 30 Jun 2025
Q1 2025 567% -28% -4.8% 31 Mar 2025
Q4 2024 550% -102% -16% 31 Dec 2024
Q3 2024 563% -92% -14% 30 Sep 2024
Q2 2024 576% -81% -12% 30 Jun 2024
Q1 2024 595% -95% -14% 31 Mar 2024
Q4 2023 652% -23% -3.3% 31 Dec 2023
Q3 2023 655% -16% -2.4% 30 Sep 2023
Q2 2023 657% -47% -6.7% 30 Jun 2023
Q1 2023 690% -105% -13% 31 Mar 2023
Q4 2022 675% -171% -20% 31 Dec 2022
Q3 2022 671% -243% -27% 30 Sep 2022
Q2 2022 704% -135% -16% 30 Jun 2022
Q1 2022 795% 31 Mar 2022
Q4 2021 846% 31 Dec 2021
Q3 2021 914% 30 Sep 2021
Q2 2021 839% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.